Internship

Vertex Summer 2025 Intern

Analytical Development

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$20 - $27/hr

No H1B Sponsorship

Boston, MA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Vertex Pharmaceuticals referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Enrolled in an undergraduate with a major in Cellular and Molecular Biology, Biochemistry, Chemical Engineering or related discipline
  • Familiarity and understanding of aseptic technique and experience with working with human cell lines/primary human cells
  • A strong understanding of cellular and molecular biology as well as separation techniques like ddPCR, RT-qPCR, PCR, ELISA, HPLC, Flow cytometry
  • Has basic data analysis understanding and displays high levels of curiosity in learning how to apply new technologies for cell and gene therapy applications
  • Strong organizational skills and high attention to details
  • Ability to communicate results both orally and in written format
  • Legal authorization to work in the United States, now and in the future
  • Candidate must be enrolled in an advanced degree program if graduating before May 2025
  • Candidate must be available to work full-time, 40 hours per week from May - August 2025
Responsibilities
  • Works closely with other members of CGAT team to coordinate analytical testing of cell culture material
  • Routinely execute different molecular, biochemical and cellular assays using robotic liquid handlers like Hamilton, Tecan, JANUS, Bravo etc.
  • Troubleshoot problems that may arise during regular operation of routine testing
  • Perform preliminary data analysis for samples run using the different analytical techniques
  • Be able to compile results obtained from routine testing and effectively communicate the same to key stakeholders
  • Maintain clear, detailed, and complete experimental records of the tasks performed
  • Work cross-functionally across multiple teams
Desired Qualifications
  • Experience working with liquid handlers is a big plus
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's EU approval expands its cystic fibrosis treatment market.
  • Partnerships with Arbor and Orna enhance Vertex's gene therapy capabilities.
  • Increased focus on personalized medicine aligns with Vertex's patient-centric approach.

What critics are saying

  • Increased competition in cystic fibrosis could impact Vertex's market share.
  • Regulatory changes in the EU may delay Vertex's drug approvals.
  • High R&D costs and potential trial failures could strain Vertex's finances.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's innovative cell and gene therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.